Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.54 |
| ▸ | NPC1 | O15118 | 8/20 | 0.54 |
| ▸ | PKM | P14618 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | PIM1 | P11309 | 1/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | FLT3 | P36888 | 1/20 | 0.51 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.51 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7904906 | 0.81 | KMT2A (0.54) | RAB9ANPC1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11549494 | 0.76 | RAB9A (0.52) | RAB9ANPC1PKMGAAMEN1 | |
| SCHEMBL9599045 | 0.75 | NPC1 (0.63) | RAB9ANPC1PKMGAAMEN1 | |
| SCHEMBL519066 | 0.74 | RAB9A (0.73) | RAB9ANPC1PKMGAAMEN1 | |
| SCHEMBL2634981 | 0.73 | RAB9A (0.56) | RAB9ANPC1PKMGAAMEN1 | |
| SCHEMBL9750118 | 0.72 | NPC1 (0.81) | RAB9ANPC1PKMGAAMEN1 | |
| SCHEMBL30565139 | 0.72 | RAB9A (1.00) | RAB9ANPC1PKMGAAMEN1 | |
| SCHEMBL7663329 | 0.71 | RAB9A (0.53) | RAB9ANPC1PKMGAAMEN1 | |
| SCHEMBL7742894 | 0.71 | GAA (0.47) | RAB9ANPC1PKMGAAMEN1 | |
| SCHEMBL7165468 | 0.71 | RAB9A (0.81) | RAB9ANPC1PKMGAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230098760-A1 | FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE | FIRMENICH SA (CH) | 2023-03-30 | — | — | US | claimed |
| WO-2021156242-A1 | FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE | FIRMENICH SA (CH) | 2021-08-12 | — | — | WO | claimed |
| US-20230098760-A1 | FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE | FIRMENICH SA (CH) | 2023-03-30 | — | — | US | disclosed |
| WO-2021156242-A1 | FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE | FIRMENICH SA (CH) | 2021-08-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230098760-A1 | FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE | TRPC5, TRPA1, CYP3A5 | RAB9A 4776/4885NPC1 1281/4885PKM 2602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.